North Carolina Board of Nursing 21 NCAC36.0800 “Approval and Practice Parameters for Nurse Practitioners” and similar Medical Board Rule 21 NCAC32M.0100 “Approval of Nurse Practitioners” came into effect on August 1, 2004. What should be included in the collaborative practice agreement? The joint subcommittee of the Care Committee and the Medical Commission does not require a specific format to be used by the care practitioner. However, any primary medicine practitioner must deal with how this primary practitioner/supervisor implements the Nurse Practitioner Rules in this practice in order to comply with the administrative code or administrative provisions. Because practices are different, collaborative practice agreements will also be different depending on the type of patients served; The most common diagnoses are made The complexity of customer care Availability of emergency services, diagnostic centres and specialists; and if the nurse practitioner has just finished against an “experienced” nurse practitioner, or the “experienced” nurse practitioner in a new field of practice, or with a new primary supervisory physician. Nurse practitioners may continue to use written protocols or other specific references that are described as such in the collaborative practice agreement, although written protocols are not mandatory, as in previous rules of law nurse practice. They may include in the agreement on practice collaborating certain references consulted, for example. B guidelines on patient care. The Nurse Collaborative Practice Agreement must provide order for nurse practitioners – physicians are always available for each other for follow-up, advice, collaboration, transfer and evaluation of care provided by nursing practitioners. When the nurse practitioner and primary supervisor will talk about how they practice together, the completed document will be nurse Practitioner`s collaborative practice agreement. CPA legislation varies from state to state. This relates to the specific services that pharmacists are allowed to provide under a CPA, as well as the terms of the agreement (for example.

B requirements for the extension of the CPA). Wisconsin Act 294, for example, has been described by the American Pharmacists Association (APhA) as granting some of the broadest powers to pharmacists in any CPA government law. [6] [20] CPAs are a lobbying priority for professional pharmaceutical organizations. In January 2012, the American Pharmacists Association (APhA) brought together a consortium of pharmacy, medical and care professionals from 12 countries to discuss the integration of CPAs into daily clinical practice. [53] The consortium published a white paper entitled “Consortium Recommendations for Advancing Pharmacists” Patients Care Services and Collaborative Practice Agreements and summarized their recommendations. [18] Advanced pharmacy services under a CPA are described as collaborative management of drug therapy (CDTM). [a] While traditional practice for pharmacists provides that the legal authority recognizes drug-related problems (DOP) and proposes solutions for PDs to prescription persons (e.g. B physicians), pharmacists who offer CDTMs solve PDs directly when they recognize them.